Literature DB >> 24271139

Intraoperative sRAGE kinetics. A new age-related outcome predictor of cardiac surgery.

A Simm1, C Philipp, I Friedrich, R J Scheubel, H-S Hofmann, K H Meibodi, A Sablotzki, R-E Silber, J Börgermann.   

Abstract

BACKGROUND: Glycated proteins (advanced glycation endproducts, AGE) in tissue are associated with degenerative diseases. This study evaluated the role of sRAGE (soluble receptor for advanced glycation endproducts), a decoy receptor of AGEs in blood, for the outcome of patients after coronary artery bypass grafting (CABG).
METHODS: A total of 90 patients undergoing CABG were analysed in two centres. Perioperative blood samples were collected before surgery up to 1 week postoperatively. sRAGE was measured by ELISA. Patients were subdivided regarding age (< 64 versus > 70 years, 14 % versus 35 % female), euroSCORE (< 3 versus > 4, 14 % versus 29 % female) and sRAGE changes between sternotomy and end of the operation (< 30 % versus > 45 %, 33 % versus 33 % female) and subsequently analysed with respect of postoperative outcome parameters.
RESULTS: Preoperative sRAGE values did not correlate with the outcome of the patients. sRAGE levels increase within 10 min from 1,539 ± 96 to 5,311 ± 187 pg/ml after sternotomy, then returning to baseline levels within 2 days after surgery. Comparing the analysed possible risk factors age, euroSCORE and sRAGE changes, no difference was observed regarding 30-day mortality. Age and the euroSCORE are superior with respect of tachyarrythmia, whereas sRAGE kinetics seems to be superior with respect of prolonged postoperative respiration time/stay in the intensive care unit or catecholamine support.
CONCLUSION: A prolonged, increased intraoperative sRAGE level is a new outcome predictor for patients undergoing CABG surgery, mutually complementary to the euroSCORE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24271139     DOI: 10.1007/s00391-013-0523-7

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  22 in total

1.  Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Authors:  D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

Review 2.  Advanced glycation end products, diabetes and ageing.

Authors:  N Nass; B Bartling; A Navarrete Santos; R J Scheubel; J Börgermann; R E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

3.  Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.

Authors:  Sergio Raposeiras-Roubín; Bruno K Rodiño-Janeiro; Lilian Grigorian-Shamagian; María Moure-González; Ana Seoane-Blanco; Alfonso Varela-Román; Ezequiel Alvarez; José R González-Juanatey
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

4.  Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts.

Authors:  S Daoud; R Schinzel; A Neumann; C Loske; D Fraccarollo; C Diez; A Simm
Journal:  Mol Med       Date:  2001-08       Impact factor: 6.354

5.  Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.

Authors:  M C Thomas; J Söderlund; M Lehto; V-P Mäkinen; J L Moran; M E Cooper; C Forsblom; P-H Groop
Journal:  Diabetologia       Date:  2011-05-24       Impact factor: 10.122

6.  Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.

Authors:  Matthieu Jabaudon; Emmanuel Futier; Laurence Roszyk; Elodie Chalus; Renaud Guerin; Antoine Petit; Segolene Mrozek; Sebastien Perbet; Sophie Cayot-Constantin; Christian Chartier; Vincent Sapin; Jean-Etienne Bazin; Jean-Michel Constantin
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

7.  Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

Authors:  Colomba Falcone; Enzo Emanuele; Angela D'Angelo; Maria P Buzzi; Chiara Belvito; Mariaclara Cuccia; Diego Geroldi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

8.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

Authors:  M T Goova; J Li; T Kislinger; W Qu; Y Lu; L G Bucciarelli; S Nowygrod; B M Wolf; X Caliste; S F Yan; D M Stern; A M Schmidt
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

9.  Survival after coronary revascularization in the elderly.

Authors:  Michelle M Graham; William A Ghali; Peter D Faris; P Diane Galbraith; Colleen M Norris; Merril L Knudtson
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

10.  Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting.

Authors:  Robert J Scheubel; Holger Zorn; Rolf-Edgar Silber; Oliver Kuss; Henning Morawietz; Juergen Holtz; Andreas Simm
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

View more
  4 in total

1.  Stress: the good, the bad and the ugly?

Authors:  Manfred Gogol; Andreas Simm
Journal:  Z Gerontol Geriatr       Date:  2015-08       Impact factor: 1.281

Review 2.  Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease.

Authors:  Raphael S Pinto; Carlos A Minanni; Aécio Lopes de Araújo Lira; Marisa Passarelli
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

3.  Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG).

Authors:  Stefan Reichert; Britt Hofmann; Michael Kohnert; Alexander Navarrete Santos; Lisa Friebe; Julia Grollmitz; Hans-Günter Schaller; Susanne Schulz
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

4.  Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis.

Authors:  Edina Korça; Veronika Piskovatska; Jochen Börgermann; Alexander Navarrete Santos; Andreas Simm
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.